Teva Pharmaceutical Industries Limited (TLV:TEVA)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
5,028.00
-31.00 (-0.61%)
Apr 17, 2025, 2:24 PM IDT
1.58%
Market Cap 57.72B
Revenue (ttm) 60.26B
Net Income (ttm) -5.97B
Shares Out n/a
EPS (ttm) -5.28
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 835,598
Average Volume 1,270,245
Open 5,003.00
Previous Close 5,059.00
Day's Range 5,003.00 - 5,035.00
52-Week Range 4,807.00 - 8,431.00
Beta 0.72
RSI 28.81
Earnings Date May 7, 2025

About TLV:TEVA

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The com... [Read more]

Sector Healthcare
Founded 1901
Employees 35,686
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol TEVA
Full Company Profile

Financial Performance

In 2024, TLV:TEVA's revenue was $16.54 billion, an increase of 4.40% compared to the previous year's $15.85 billion. Losses were -$1.64 billion, 193.2% more than in 2023.

Financial numbers in USD Financial Statements

News

BMO's Siegerman talks the impact of tariffs on pharmaceutical stocks

Evan Seigerman, BMO, joins 'Fast Money' to talk the impact of tariffs on pharma space.

9 days ago - CNBC Television

Trump's Tariffs Circle Pharma Industry: Who It Affects And How It May Play Out

The Trump administration's proposed tariffs on pharmaceuticals have caused significant market turmoil today, with major Pharma stocks plummeting globally. Despite pledges to increase U.S. manufacturin...

9 days ago - Seeking Alpha

Teva Announces FDA Filing Acceptance for AJOVY® (fremanezumab) in Pediatric Episodic Migraine Prevention

PARSIPPANY, N.J. and TEL AVIV, April 07, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced today that the U.S. Foo...

11 days ago - GlobeNewsWire

New Data Strengthens Teva’s Schizophrenia Portfolio, Including Phase 3 SOLARIS Trial Survey Results Demonstrating Patient and Healthcare Professional Satisfaction with TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable

More than 92% of schizophrenia patients taking TEV-‘749 in the SOLARIS survey were satisfied or very satisfied with the initiation regimen, dosing schedule and trial medication1 New data from UZEDY® (...

18 days ago - Financial Post

New Data Strengthens Teva's Schizophrenia Portfolio, Including Phase 3 SOLARIS Trial Survey Results Demonstrating Patient and Healthcare Professional Satisfaction with TEV-'749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable

PARSIPPANY, N.J. and TEL AVIV, Israel, March 31, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the prese...

18 days ago - GlobeNewsWire

Teva Releases Q1 2025 Aide Memoire

TEL AVIV, Israel, March 27, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q1 2025 Aide Memoire is available on the "Investors" page on its...

22 days ago - Benzinga

Teva Releases Q1 2025 Aide Memoire

TEL AVIV, Israel, March 27, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q1 2025 Aide Memoire is available on the “Investors” page on its...

22 days ago - GlobeNewsWire

Teva to Host Conference Call to Discuss First Quarter 2025 Financial Results at 8 a.m. ET on May 7, 2025

TEL AVIV, Israel, March 27, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its first quarter 2025 financial re...

22 days ago - GlobeNewsWire

Teva Pharmaceutical Indus Unusual Options Activity

Financial giants have made a conspicuous bearish move on Teva Pharmaceutical Indus. Our analysis of options history for Teva Pharmaceutical Indus (NYSE: TEVA) revealed 8 unusual trades. Delving into ...

22 days ago - Benzinga

Teva Pharmaceutical Industries Ltd at Barclays Global Healthcare Conference Transcript

Teva Pharmaceutical Industries Ltd at Barclays Global Healthcare Conference Transcript

4 weeks ago - GuruFocus

Teva Pharmaceutical Industries Ltd to Discuss New Data Presented for Duvakitug (Anti-TL1A) ...

Teva Pharmaceutical Industries Ltd to Discuss New Data Presented for Duvakitug (Anti-TL1A) Phase 2b after ECCO Conference Call Transcript

4 weeks ago - GuruFocus

Teva Pharmaceutical Industries Ltd at JPMorgan Healthcare Conference Transcript

Teva Pharmaceutical Industries Ltd at JPMorgan Healthcare Conference Transcript

4 weeks ago - GuruFocus

Teva Pharmaceutical Stock Scores RS Rating Upgrade

Teva Pharmaceutical ADR shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

4 weeks ago - Investor's Business Daily

Drugmakers agree to participate in second round of price negotiations

All drug manufacturers, including Novo Nordisk and Teva Pharmaceuticals , whose medicines are part of the second round of price talks have agreed to participate in the negotiation process, a federal h...

5 weeks ago - Reuters

Teva Pharmaceutical Industries Limited (TEVA) Leerink's 2025 Global Healthcare Conference (Transcript)

Teva Pharmaceutical Industries Limited (NYSE:TEVA) Leerink's 2025 Global Healthcare Conference March 12, 2025 8:40 AM ETCompany ParticipantsRichard Francis...

5 weeks ago - Seeking Alpha

This Is What Whales Are Betting On Teva Pharmaceutical Indus

Financial giants have made a conspicuous bullish move on Teva Pharmaceutical Indus. Our analysis of options history for Teva Pharmaceutical Indus (NYSE: TEVA) revealed 8 unusual trades. Delving into ...

6 weeks ago - Benzinga

Deckers Outdoor Corp (DECK) Unveils Teva's Spring-Summer 2025 Collection

Deckers Outdoor Corp (DECK) Unveils Teva's Spring-Summer 2025 Collection

6 weeks ago - GuruFocus

Teva to Present at Barclays Global Healthcare Conference and Leerink Partners Global Healthcare Conferences in March

TEL AVIV, Israel, March 03, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at two upcom...

6 weeks ago - GlobeNewsWire

2025 Community Routes: Access to Mental Health Care Grants Awarded to Clinics in Alabama, Mississippi, and Texas, Funded by Teva Pharmaceuticals

The $2 million in new funding is part of a $4 million commitment from Teva, launched in 2022, to expand access to critical mental health services across 10 states The $2 million in new funding is part...

7 weeks ago - GlobeNewsWire